MD
Mehul DamaFund Manager Since 6 Jul 2021
EquitySector - Healthcare
Nippon India Nifty Pharma ETF
3Y Annualised
N/A
-0.05% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
0.00%
-0.05% 1D
Benchmark
SBI Nifty 10 yr Benchmark G-Sec ETF
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
This Fund
NA
NIFTY 50
8 years 10 months
FD
9 years 7 months
Fund info
Fund size
₹1691.41 Cr
Min. SIP amount
₹1000
Min. Lumpsum amount
₹1000
Exit load
0%
Risk Profile
Very High Risk
Peer Comparison
This Fund's Performance Compared With Peers
Over the Period of oneMonth
Fund Managers
About Nippon India Nifty Pharma ETF
Nippon India Nifty Pharma ETF is a Equity mutual fund scheme from Nippon Life India Asset Management Ltd. This fund has been in existence for 5 years, having been launched on 2021-07-06. Nippon India Nifty Pharma ETF has ₹1691.41 Cr worth of assets under management (AUM) as of Thu Sep 03 2026. The latest Net Asset Value (NAV) of Nippon India Nifty Pharma ETF as of Wed Sep 02 2026 is ₹27.5413. The fund has an expense ratio of 0.21%, which is medium comparable to most other Equity funds.
Nippon India Nifty Pharma ETF returns for the last 1 year are NA%. Since launch, it has delivered % average annual returns.
The Nippon India Nifty Pharma ETF has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of Nippon India Nifty Pharma ETF.
- Sun Pharmaceuticals Industries Ltd: 21.29%
- Divi's Laboratories Ltd: 10.34%
- Cipla Ltd: 8.37%
- Torrent Pharmaceuticals Ltd: 7.59%
- Laurus Labs Ltd: 7.14%
AMC Information
| Name | Nippon Life India Asset Management Ltd |
|---|---|
| Founding Date | 2021-07-06 |
| customercare@nipponindiaim.in | |
| Phone | 022-6808 7000/18602660111 |
| Website | https://mf.nipponindiaim.com/ |
| Address | Nippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W) |
Tax Implications of Nippon India Nifty Pharma ETF
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from Nippon Life India Asset Management Ltd
Nippon India Aggressive Hybrid Fund - Direct Plan - Growth Option
AllocationAggressive Allocation
3Y CAGR
11.56%
expense ratio
1.12%
fund size
₹4073.07 Cr
Nippon India ELSS Tax Saver Fund Direct Plan - Growth Option
EquityELSS (Tax Savings)
3Y CAGR
12.86%
expense ratio
1.12%
fund size
₹14909.88 Cr
Nippon India Multi Cap Fund - Direct Plan - Growth
EquityMulti-Cap
3Y CAGR
13.58%
expense ratio
0.84%
fund size
₹55587.00 Cr
Nippon India Equity Savings Direct Growth
AllocationEquity Savings
3Y CAGR
7.22%
expense ratio
0.93%
fund size
₹800.46 Cr
Nippon India Equity Savings Growth
AllocationEquity Savings
3Y CAGR
6.16%
expense ratio
1.98%
fund size
₹800.46 Cr
Calculate Your Returns
Estimated Returns in 1 Years (Based on past 1Y returns)
₹0
Total Amount
₹0
